Pharmodynamics : Receptor Theory Flashcards

1
Q

How to calculate g/L of acetylcholine that has a molecular weight of 146 in 1M solution ?

A

MWt x Molarity = g/L

146 x 1 = 146g/L

  • molecular weight means molecular weight in GRAMS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does binding of a ligand obey the law of mass action ?

A

L + R = RLIgand receptor complex

  • reversible reaction
  • as you add more ligand or more receptor the eq would shift to the right and more ligand -receptor complexes would be made.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define affinity

A

Measure of strength of interaction between a ligand and a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does an agonist work ?

A
  • an agonist binds to a receptor.
  • binding of the agonist depends on AFFINITY
  • an agonist-receptor complex is made
  • receptor activation is governed by intrinsic efficacy which results in the receptor being activated conformation.
  • to generate a biological response EFFICACY is required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain how an antagonist works ?

A
  • antagonist binds to receptor
  • this requires AFFINITY
  • an antagonist blocks the binding of the agonist which prevents the receptor being activated.
  • they have NO intrinsic efficacy which explains why there is no response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can we measure binding of a ligand to a receptor experimentally ?

A
  • often by binding of a radioactively labelled ligand to cells or membranes
  • incubate radioligand and receptors
  • we separate the ligands that are bound and free and then measure the ligands that are bound.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is kd?

A

The concentration of drug at which 50% of receptors are occupied.

  • gives a measure of affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The lower the kd the ….. greater/lower the affinity ?

A

Greater the affinity because the lower the kd the less concentration required to occupy all 50% of receptor sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can we treat heroin or morphine overdose ?

A

Naloxone is used to treat overdose

  • it has a very high affinity ( thus lower kd) than heroin
  • high affinity antagonist of u-opioid receptors
  • and eventually outcompetes heroin in the body

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is fentanyl and why is it very difficult to treat overdose in it ?

A
  • fentanyl is an opioid that causes euphoria
  • it has an agonist which has an extremely high affinity towards opioid receptors
  • often medications like naloxone cannot outcompete fentanyl.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Log10 of number =

A

Power by which 10 has to be raised to get that number

Eg log10 ( 1000) = 3 because 10^3 = 1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does a response require in order to happen ?

A

EFFICACY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define EC50

A

Effective concentration giving 50% maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is intrinsic efficacy ?

A

Ability to activate receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define potency

A

Effective concentration that gives 50% of the maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does potency depend on ?

A
  • BOTH AFFINITY
  • intrinsic efficacy
  • PLUS cell/tissue components eg number of receptors
17
Q

Define concentration and dose

A

Concentration - known concentration of drug at site of action

  • dose : concentration at site of action generally unknown eg dose to a patient in mg or mg/kg
18
Q

Why when treating asthma we need a highly selective drug ?

A

-drugs that act as agonists tend to target b2-adrenoreceptors in the airways , however because b-adrenoreceptors are elsewhere in the body eg b1-adrneoreceptors are found in the heart , non-selective drugs may increase force and rate of contraction!

19
Q

How does Salbutamol achieve selective specificity ?

A

Kd for b2- 1micromoles
Kd for b1- 20micromoles

  • this shows that there is only a 20 fold difference between the affinity towards beta1 and beta2 adrenoreceptors. Which suggests that selectivity is not that great. HOWEVER…
  • when salbutamol binds to beta2- adrenoreceptors, the receptors are activated very well compared to beta1-adrenoreceptors which suggests that salbutamol is enhanced by b2-selective efficacy.
20
Q

How does salmeterol achieve selective specificities

A
  • long acting drug
  • kd b1- 1900nm
  • kd b2- 0.5nm

= there is a 3455 fold difference in affinity which suggests that salmeterol selectivity is based on affinity , not selective efficacy

21
Q

What are the problems with salbutamol in people who have cardiovascular disease ?

A

the b1-adrenoreceptors are also activated resulting in heart rate increasing.

  • this could lead to problems such as angina
  • hypertension
22
Q

Give an example of one cell/tissue dependant factors that influence agonist potency ?

A

Number of receptors

23
Q

How does an increase in the number of receptors increase agonist potency ?

A
  • because we often have spare receptors left over
  • for example : if there were no spare receptors ( there were 10,000 receptors in a cell ) , a full response requires 100% occupnacy . This would mean it requires&raquo_space;»> kd concentration of drug. Eg if kd of drug is 1nm it would need 10-100 Nm of drug instead.
  • HOWEVER, with spare receptors ( if we have 20,000) . Only 50% occupancy required for full response (10,000). So it requires kd of drug. Eg if kd=1nm, it requires 1nm.
24
Q

Does changing receptors number affect maximal response ?

A

Yes it can

-

25
How does receptors numbers vary in the body ?
- they vary with cell type - they tend to increase with low activity in the cell , to up regulation - they tend to decrease with high activity to down regulation
26
Define a partial agonist
- a- binds to receptors , however has insufficient intrinsic efficacy for maximal response to be evoked. Thus , EMAX decreases.
27
Give an example of a partial agonist that can be used to treat heroin addictions
Buprenorphine
28
Outline how the partial agonist buorenorphine acts as an agonist but also an antagonist at the same time
1) buprenorphine has a higher affinity for the u-opioid receptors than heroin so would bind to the receptors preventing the binding of heroin thus acting as an antagonist - at the same time it activates the receptors , but not enough to evoke a maximal response.
29
Why can a heroin addict become very ill if they administered buprenorphine ?
Addict experiences withdrawal symptoms because buprenorphine is a partial agonist which means it would not evoke a maximal response at the opioid receptors which the body is not used to,
30
What are the three types of antagonists?
1( reversible competitive antagonist 2) irreversible competitive antagonist 3) non competitive antagonist
31
Define IC50
Concentration of antagonist giving 50% inhibition
32
Reversible competitive antagonist
Competitive antagonists compete with agonist for binding - the inhibition is surmountable - causes a parallel shift to the right of the agonist - concentration response curve because more agonist concentration is required to outcompete the competitive antagonist
33
Give an example of a reversible competitive antagonist
- naloxone - high affinity for u-opioid receptors -
34
Irreversible competitive antagonists
- with increased antagonist or increased time more receptors are blocked by antagonist - this is non-surmountable - this would cause a parallel shift to the right of the graph and at higher concentrations suppress the maximal response ( EMAX decreases)
35
Define orthosteric site
- the binding site where a ligand usually binds aka the active site
36
Non competitive antagonist
- binds to sllosteric site which results in a conformational change - this reduces orthosteric ligand affinity / and or efficacy - causes a parallel shift to the right - decreases maximal response at higher concentrations of non comp antagonist
37
What is an example of a non competitive antagonist drug
Maraviroc